Journal of Hematology & Oncology

Journal of Hematology & Oncology is a peer-reviewed open-access online journal published by BioMed Central (BMC, part of Springer Nature) and founded in 2008, covering all aspects of hematology and oncology, with a 2025 Journal Impact Factor of 47.8《血液学与肿瘤学杂志》是由施普林格·自然（Springer Nature）旗下的（BioMed Central）出版、2008 年创办的同行评审开放获取在线期刊，涵盖血液学与肿瘤学的所有方面，2025 年影响因子为 47.8。

Scope

• It publishes top-quality research encompassing all aspects of hematology and oncology, the two closely intertwined and rapidly evolving fields该刊刊载涵盖血液学与肿瘤学所有方面的优质研究，这两个领域紧密交织且发展迅速。
• It aims to serve as an international platform for sharing laboratory and clinical findings among laboratory scientists, physician scientists, hematologists and oncologists该刊旨在成为国际平台，供实验室科学家、医师科学家、血液科医师与肿瘤科医师分享实验室与临床研究发现。
• It publishes reviews and research highlights on hot topics written by leading experts in the field该刊刊载由领域内顶尖专家撰写的热点主题综述与研究亮点。
• It brings research from bench to bedside, meeting the demand for a journal dedicated to publishing discovery from both hematology and oncology该刊推动研究从实验室走向临床，满足了对同时刊载血液学与肿瘤学发现的期刊的需求。
• Article types include original research, reviews, correspondences and editorials, together with collections on specialised themes文章类型包括原创研究、综述、通讯与社论，并设有专题合辑。
• A rapid turnaround time from submission to publication means knowledge and new successes can be shared in real time从投稿到发表周转迅速，使知识与新成果得以实时共享。
• As an open access journal it publishes articles as soon as they are ready and levies an article-processing charge, with waivers for authors from low-income countries作为开放获取期刊，文章一经就绪即行发表，并收取论文处理费，对来自低收入国家的作者予以减免。

History

• The journal was founded by Delong Liu in 2008, and its first volume was published in that year, with the founding editorial released online on 28 May 2008该刊由刘德龙（Delong Liu）于 2008 年创办，同年出版第 1 卷，创刊社论于 2008 年 5 月 28 日在线发表。^[1]
• It is the official journal of the Chinese American Hematologist and Oncologist Network (CAHON)该刊是华人美国血液与肿瘤医师网络（Chinese American Hematologist and Oncologist Network，CAHON）的官方会刊。
• It is published by BioMed Central, part of Springer Nature, and appears online only without a print edition该刊由施普林格·自然（Springer Nature）旗下的（BioMed Central）出版，仅在线发行，无印刷版。
• It has been fully open access since launch, with authors retaining copyright and granting third parties rights under the BMC license agreement该刊自创刊起即为完全开放获取，作者保留版权，并依据（BMC）许可协议授予第三方使用权。
• Its Journal Impact Factor rose from 17.388 in 2021 to 47.8 in 2025, with a 2023 Journal Impact Factor of 29.9 and a five-year Journal Impact Factor of 27.1该刊影响因子由 2021 年的 17.388 升至 2025 年的 47.8，2023 年影响因子为 29.9，五年影响因子为 27.1。
• In 2025 it ranked first among 103 hematology journals and sixth among 333 oncology journals, placing in the first quartile in both categories2025 年该刊在 103 种血液学期刊中排名第 1，在 333 种肿瘤学期刊中排名第 6，两个类别均位列第一四分位。

Editors

• The Editor-in-Chief is Delong Liu, MD, PhD, of New York Medical College, USA, who is the founding Editor-in-Chief of the journal现任主编为刘德龙（Delong Liu），医学博士，来自（New York Medical College），是该刊的创刊主编。
• The Deputy Editor-in-Chief is Kongming Wu, MD, PhD, of Tongji Medical College of Huazhong University of Science and Technology, China副主编为吴孔明（Kongming Wu），医学博士，来自（Tongji Medical College of Huazhong University of Science and Technology）。
• Section Editors include Narendranath Epperla of the University of Utah and Hongtao Liu of the University of Wisconsin-Madison, both in the USA分区编辑包括（Narendranath Epperla）与（Hongtao Liu），分别来自（University of Utah）与（University of Wisconsin-Madison），均在美国。
• Senior Associate Editors include Franco Cavalli, Jorge Cortes, Xiao-Jun Huang, Azra Raza, Lucio Luzzatto and Depei Wu, spanning Switzerland, the USA, China and Tanzania资深副编辑包括 Franco Cavalli、Jorge Cortes、黄晓军（Xiao-Jun Huang）、Azra Raza、Lucio Luzzatto 与吴德沛（Depei Wu），遍及瑞士、美国、中国与坦桑尼亚。
• Its editorial board is international, drawing members from universities and cancer centres across the USA, China, Europe and other regions该刊编委会具有国际化特征，成员来自美国、中国、欧洲及其他地区的多所大学与癌症中心。
• It operates a single-blind peer-review system, in which reviewers know author names but reviewer reports to authors are anonymous, with two or more experts assessing each manuscript该刊采用单盲同行评审（single-blind peer review），评审人知晓作者身份而作者收到的评审报告匿名，每篇稿件由两名或以上专家评审。